header
Local cover image
Local cover image
Image from OpenLibrary

Human Interleukin 12 gene as a biomarker for response to interferon treatment in hepatitis C virus patients / Asmaa Mostafa Abdelaal Mohamed ; Supervised Samar Samir Youssef , Amr Saad Mohamed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Asmaa Mostafa Abdelaal Mohamed , 2013Description: 135 P. : charts ; 25cmOther title:
  • جين الإنترلوكين 12 فى الانسان كدليل حيوى للإستجابة لعلاج الإنترفيرون فى المرضى المصابين بفيروس الإلتهاب الكبدى الوبائى سى [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry Summary: Introduction: Hepatitis C virus (HCV) infection"The silent killer" is a global blood-borne disease that affects almost 3% of the worlds population with the highest prevalence in Egypt (15%). the standard therapy, PEG-IFN and ribavirin , is effective in only 60% of Egyptian patients; moreover it is costly, prolonged and have severe side effects, so prediction of response is essential to reduce burden of unfavorable treatment
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.M.Sc.2013.As.H (Browse shelf(Opens below)) Not for loan 01010110063129000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.M.Sc.2013.As.H (Browse shelf(Opens below)) 63129.CD Not for loan 01020110063129000

Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry

Introduction: Hepatitis C virus (HCV) infection"The silent killer" is a global blood-borne disease that affects almost 3% of the worlds population with the highest prevalence in Egypt (15%). the standard therapy, PEG-IFN and ribavirin , is effective in only 60% of Egyptian patients; moreover it is costly, prolonged and have severe side effects, so prediction of response is essential to reduce burden of unfavorable treatment

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image